Hansoh Pharma Initiates Clinical Trials for Two Innovative Drugs HS-10370 and HS-10382 on the Same Day
Hansoh Pharma
Pharmaceutical Research, Production, and Sales
On March 28, the Insight database showed that Hansoh Pharma's two innovative drugs, HS-10370 and HS-10382, were registered to start clinical trials on the same day.
Hansoh Pharma Registered Clinical Trial on March 28
Source: Insight Database (http://db.dxy.cn/v5/home/)
According to the Insight database, Hansoh Pharma entered a boom period for new drug applications in 2021, with up to 14 new drug projects applying for clinical trials for the first time. Most of these were chemical drugs, but there were also two biological product new drug applications.
Clinical Application Status of Innovative Drug Projects by Hansoh Pharma in the Past Five Years
*Only the first declaration is counted
Source: Insight Database (http://db.dxy.cn/v5/home/)
In terms of the distribution of R&D phases, Hansoh Pharma has accumulated a large number of Phase I clinical trials and projects approved for clinical trials. The subsequent progress is worth looking forward to.
